View in EDS

FLT3 inhibitors potentially improve response rates in acute myeloid leukemia harboring t(6;9)(DEK::NUP214): the Mayo Clinic experience.

Saved in:
Bibliographic Details
Title: FLT3 inhibitors potentially improve response rates in acute myeloid leukemia harboring t(6;9)(DEK::NUP214): the Mayo Clinic experience.
Authors: Csizmar CM; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN., Saliba AN; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN., Greipp PT; Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN., Alkhateeb H; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN., Begna KH; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN., Foran JM; Division of Hematology and Medical Oncology, Department of Medicine, Mayo Clinic, Jacksonville, FL., Gangat N; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN., Hogan WJ; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN., Hook CC; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN., Litzow MR; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN., Mangaonkar AA; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN., Palmer JM; Division of Hematology and Medical Oncology, Department of Medicine, Mayo Clinic, Phoenix, AZ., Pardanani A; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN., Shah MV; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN., Tefferi A; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN., Torghabeh MH; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN., Wolanskyj-Spinner AP; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN., Patnaik MM; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN., Kaufmann SH; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA; Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN. kaufmann.scott@mayo.edu., Al-Kali A; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN. alkali.aref@mayo.edu.
Source: Haematologica [Haematologica] 2024 Nov 01; Vol. 109 (11), pp. 3785-3789. Date of Electronic Publication: 2024 Nov 01.
Publication Type: Journal Article
Journal Info: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38899336
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: FLT3 inhibitors potentially improve response rates in acute myeloid leukemia harboring t(6;9)(DEK::NUP214): the Mayo Clinic experience.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Csizmar+CM%22">Csizmar CM</searchLink>; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.<br /><searchLink fieldCode="AU" term="%22Saliba+AN%22">Saliba AN</searchLink>; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.<br /><searchLink fieldCode="AU" term="%22Greipp+PT%22">Greipp PT</searchLink>; Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.<br /><searchLink fieldCode="AU" term="%22Alkhateeb+H%22">Alkhateeb H</searchLink>; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.<br /><searchLink fieldCode="AU" term="%22Begna+KH%22">Begna KH</searchLink>; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.<br /><searchLink fieldCode="AU" term="%22Foran+JM%22">Foran JM</searchLink>; Division of Hematology and Medical Oncology, Department of Medicine, Mayo Clinic, Jacksonville, FL.<br /><searchLink fieldCode="AU" term="%22Gangat+N%22">Gangat N</searchLink>; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.<br /><searchLink fieldCode="AU" term="%22Hogan+WJ%22">Hogan WJ</searchLink>; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.<br /><searchLink fieldCode="AU" term="%22Hook+CC%22">Hook CC</searchLink>; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.<br /><searchLink fieldCode="AU" term="%22Litzow+MR%22">Litzow MR</searchLink>; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.<br /><searchLink fieldCode="AU" term="%22Mangaonkar+AA%22">Mangaonkar AA</searchLink>; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.<br /><searchLink fieldCode="AU" term="%22Palmer+JM%22">Palmer JM</searchLink>; Division of Hematology and Medical Oncology, Department of Medicine, Mayo Clinic, Phoenix, AZ.<br /><searchLink fieldCode="AU" term="%22Pardanani+A%22">Pardanani A</searchLink>; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.<br /><searchLink fieldCode="AU" term="%22Shah+MV%22">Shah MV</searchLink>; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.<br /><searchLink fieldCode="AU" term="%22Tefferi+A%22">Tefferi A</searchLink>; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.<br /><searchLink fieldCode="AU" term="%22Torghabeh+MH%22">Torghabeh MH</searchLink>; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.<br /><searchLink fieldCode="AU" term="%22Wolanskyj-Spinner+AP%22">Wolanskyj-Spinner AP</searchLink>; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.<br /><searchLink fieldCode="AU" term="%22Patnaik+MM%22">Patnaik MM</searchLink>; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.<br /><searchLink fieldCode="AU" term="%22Kaufmann+SH%22">Kaufmann SH</searchLink>; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA; Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN. kaufmann.scott@mayo.edu.<br /><searchLink fieldCode="AU" term="%22Al-Kali+A%22">Al-Kali A</searchLink>; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN. alkali.aref@mayo.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220417435%22">Haematologica</searchLink> [Haematologica] 2024 Nov 01; Vol. 109 (11), pp. 3785-3789. <i>Date of Electronic Publication: </i>2024 Nov 01.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Ferrata+Storti+Foundation%22">Ferrata Storti Foundation </searchLink><i>Country of Publication: </i>Italy <i>NLM ID: </i>0417435 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1592-8721 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203906078%22">03906078 </searchLink><i>NLM ISO Abbreviation: </i>Haematologica <i>Subsets: </i>MEDLINE; In Process
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38899336
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3324/haematol.2024.285359
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 3785
    Titles:
      – TitleFull: FLT3 inhibitors potentially improve response rates in acute myeloid leukemia harboring t(6;9)(DEK::NUP214): the Mayo Clinic experience.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Csizmar CM
      – PersonEntity:
          Name:
            NameFull: Saliba AN
      – PersonEntity:
          Name:
            NameFull: Greipp PT
      – PersonEntity:
          Name:
            NameFull: Alkhateeb H
      – PersonEntity:
          Name:
            NameFull: Begna KH
      – PersonEntity:
          Name:
            NameFull: Foran JM
      – PersonEntity:
          Name:
            NameFull: Gangat N
      – PersonEntity:
          Name:
            NameFull: Hogan WJ
      – PersonEntity:
          Name:
            NameFull: Hook CC
      – PersonEntity:
          Name:
            NameFull: Litzow MR
      – PersonEntity:
          Name:
            NameFull: Mangaonkar AA
      – PersonEntity:
          Name:
            NameFull: Palmer JM
      – PersonEntity:
          Name:
            NameFull: Pardanani A
      – PersonEntity:
          Name:
            NameFull: Shah MV
      – PersonEntity:
          Name:
            NameFull: Tefferi A
      – PersonEntity:
          Name:
            NameFull: Torghabeh MH
      – PersonEntity:
          Name:
            NameFull: Wolanskyj-Spinner AP
      – PersonEntity:
          Name:
            NameFull: Patnaik MM
      – PersonEntity:
          Name:
            NameFull: Kaufmann SH
      – PersonEntity:
          Name:
            NameFull: Al-Kali A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: 2024 Nov 01
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1592-8721
          Numbering:
            – Type: volume
              Value: 109
            – Type: issue
              Value: 11
          Titles:
            – TitleFull: Haematologica
              Type: main
ResultId 1